semaglutide on medicaid Weight loss drugs covered by Medicaid? Senate could decide soon TennCare's obesity medication coverage is

From a clinical standpoint, the message is clear: - Yes to metabolic monitoring - Yes to awareness of glycemic risk - But no to avoiding statins out of fear of diabetes, especially in patients at high cardiovascular risk The real question isnt: Do statins cause diabetes? but rather: Does cardiovascular benefit outweigh metabolic risk? And once again, the answer is: yes

But studies also show a quarter of the once-hopeful abandon their goals within the first week, and more than half quit by Feb

Book Your GLP-1 Consultation at Z Med Clinic & Med Spa in Texas Start your wellness journey with GLP-1-based weight management support at Z Med Clinic in Texas

From my perspective as a physician specializing in obesity medicine, GLP-1 medications like semaglutide have truly changed the game

Not theoretical

Finally, summarizing the data on metabolic outcomes is challenging because of significant variability in effects